Aspergillus Infections and Progression of Structural Lung Disease in Children with Cystic Fibrosis

被引:45
|
作者
Breuer, Oded [1 ,3 ,4 ]
Schultz, Andre [1 ,2 ,4 ]
Garratt, Luke W. [1 ]
Turkovic, Lidija [1 ]
Rosenow, Tim [1 ,2 ]
Murray, Conor P. [5 ]
Karpievitch, Yuliya, V [1 ]
Akesson, Lauren [1 ,6 ,7 ]
Dalton, Samuel [8 ]
Sly, Peter D. [9 ]
Ranganathan, Sarath [6 ,8 ,10 ]
Stick, Stephen M. [1 ,2 ,4 ]
Caudri, Daan [1 ,4 ,11 ]
机构
[1] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia
[2] Univ Western Australia, Fac Med & Dent, Div Child Hlth, Perth, WA, Australia
[3] Hadassah Hebrew Univ, Dept Pediat, Pediat Pulm Unit, Med Ctr, Jerusalem, Israel
[4] Perth Childrens Hosp, Dept Resp & Sleep Med, Perth, WA, Australia
[5] Perth Childrens Hosp, Dept Diagnost Imaging, Perth, WA, Australia
[6] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
[7] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic, Australia
[8] Royal Childrens Hosp, Dept Resp Med, Parkville, Vic, Australia
[9] Univ Queensland, Child Hlth Res Ctr, Childrens Hlth & Environm Program, Brisbane, Qld, Australia
[10] Murdoch Childrens Res Inst, Parkville, Vic, Australia
[11] Erasmus Med Ctr Sophia, Dept Pediat Resp Med, Rotterdam, Netherlands
基金
英国医学研究理事会;
关键词
cystic fibrosis; Aspergillus; trapped air; bronchiectasis; lung disease progression; CHEST COMPUTED-TOMOGRAPHY; YOUNG-CHILDREN; PSEUDOMONAS-AERUGINOSA; FUMIGATUS COLONIZATION; RISK-FACTORS; INFLAMMATION; INFANTS; SPUTUM; BRONCHIECTASIS; EXACERBATIONS;
D O I
10.1164/rccm.201908-1585OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Recent data show that Aspergillus species are prevalent respiratory infections in children with cystic fibrosis (CF). The biological significance of these infections is unknown. Objectives: We aimed to evaluate longitudinal associations between Aspergillus infections and lung disease in young children with CF. Methods: Longitudinal data on 330 children participating in the Australian Respiratory Early Surveillance Team for Cystic Fibrosis surveillance program between 2000 and 2018 who underwent annual chest computed tomography (CT) imaging and BAL were used to determine the association between Aspergillus infections and the progression of structural lung disease. Results were adjusted for the effects of other common infections, associated variables, and repeated visits. Secondary outcomes included inflammatory markers in BAL, respiratory symptoms, and admissions for exacerbations. Measurements and Main Results: Haemophilus influenzae, Staphylococcus aureus, Pseudomonas aeruginosa, and Aspergillus infections were all associated with worse CT scores in the same year (P-overall < 0.05). Only P. aeruginosa and Aspergillus were associated with progression in CT scores in the year after an infection and worse CT scores at the end of the observation period. P. aeruginosa was most significantly associated with development of bronchiectasis (difference, 0.9; 95% confidence interval, 0.3-1.6; P= 0.003) and Aspergillus with trapped air (difference, 3.2; 95% confidence interval, 1.0-5.4; P = 0.004). Aspergillus infections were also associated with markers of neutrophilic inflammation (P < 0.001) and respiratory admissions risk (P = 0.008). Conclusions: Lower respiratory Aspergillus infections are associated with the progression of structural lung disease in young children with CF. This study highlights the need to further evaluate early Aspergillus species infections and the feasibility, risk, and benefit of eradication regimens.
引用
收藏
页码:688 / 696
页数:9
相关论文
共 50 条
  • [21] Sensitive markers to detect progression of lung disease in children with cystic fibrosis
    Stahl, Mirjam
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58 (01)
  • [22] ARE STAPHYLOCOCCUS AUREUS INFECTIONS CAUSALLY RELATED TO MORE RAPID DISEASE PROGRESSION IN CHILDREN WITH CYSTIC FIBROSIS?
    Caudri, D.
    Turkovic, L.
    Ng, J.
    De Klerk, N.
    Rosenow, T.
    Hall, G.
    Ranganathan, S.
    Stick, S.
    RESPIROLOGY, 2016, 21 : 65 - 65
  • [23] Biomarkers in Paediatric Cystic Fibrosis Lung Disease
    Ramsey, Kathryn A.
    Schultz, Andre
    Stick, Stephen M.
    PAEDIATRIC RESPIRATORY REVIEWS, 2015, 16 (04) : 213 - 218
  • [24] Laboratory biomarkers for lung disease severity and progression in cystic fibrosis
    Bene, Zsolt
    Fejes, Zsolt
    Macek, Milan, Jr.
    Amaral, Margarida D.
    Balogh, Istvan
    Nagy, Bela, Jr.
    CLINICA CHIMICA ACTA, 2020, 508 : 277 - 286
  • [25] Regional differences in infection and structural lung disease in infants and young children with cystic fibrosis
    Carzino, Rosemary
    Frayman, Katherine B.
    King, Louise
    Vidmar, Suzanna
    Ranganathan, Sarath
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (06) : 917 - 922
  • [26] Ability of the lung clearance index to monitor progression of early lung disease in children with cystic fibrosis
    Foong, Rachel
    Ramsey, Kathryn
    Harper, Alana
    Turkovic, Lidija
    Skoric, Billy
    Rosenow, Tim
    King, Louise
    Davis, Miriam
    Clem, Charles
    Stick, Stephen
    Ranganathan, Sarath
    Hall, Graham
    Davis, Stephanie
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [27] Elucidating progression of early cystic fibrosis lung disease
    Ramsey, Kathryn
    Ratjen, Felix
    Latzin, Philipp
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (05)
  • [28] The evolution of lung disease in children with cystic fibrosis
    Le Bourgeois, M.
    ARCHIVES DE PEDIATRIE, 2009, 16 (06): : 576 - 577
  • [29] Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis
    Stahl, Mirjam
    Steinke, Eva
    Mall, Marcus A.
    GENES, 2021, 12 (06)
  • [30] A birth cohort approach to understanding cystic fibrosis lung infections
    Fischer, Anthony J.
    Planet, Paul J.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (01) : 8 - 11